Identification of anti-HPA-1a allo-antibodies using IgG platelet antibody detection and crossmatch system assay with Galileo Echo

References

• Kaplan C. Foetal and neonatal alloimmune thrombocytopaenia. Orphanet J Rare Dis 2006;1:39--44
   PubMed Web of Science ®Google Scholar
• Davoren A, McParland P, Barnes CA, Murphy WG. Neonatal alloimmune thrombocytopenia in the Irish population: A discrepancy between observed and expected cases. J Clin Pathol 2002;55:289–292
   PubMedGoogle Scholar
• Williamson LM, Hackett G, Rennie J, Palmer CR, Maciver C, Hadfield R, Hughes D, Jobson S, Ouwehand WH. The natural history of fetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PlA1, Zwa) as determined by antenatal screening. Blood 1998;92:2280–2287
   PubMed Web of Science ®Google Scholar
• Kaplan C. Neonatal alloimmune thrombocytopenia. Haematologica 2008;93:805–807
   PubMed Web of Science ®Google Scholar
• Peterson JA, Pechauer SM, Gitter ML, Kanack A, Curtis BR, Reese J, Kamath VM, McFarland JG, Aster RH. New platelet glycoprotein polymorphisms causing maternal immunization and neonatal alloimmune thrombocytopenia. Transfusion 2012;52:1117–1124
   PubMed Web of Science ®Google Scholar
• Mueller-Eckhardt C, Kiefel V, Grubert A, Kroll H, Weisheit M, Schmidt S, Mueller-Eckhardt G, Santoso S. 348 cases of suspected neonatal alloimmune thrombocytopenia. Lancet 1989;1:363–366
   PubMed Web of Science ®Google Scholar
• Turner ML, Bessos H, Fagge T, Harkness M, Rentoul F, Seymour J, Wilson D, Gray I, Ahya R, Cairns J, et al. Prospective epidemiologic study of the outcome and cost-effectiveness of antenatal screening to detect neonatal alloimmune thrombocytopenia due to anti-HPA-1a. Transfusion 2005;45:1945–1956
   PubMed Web of Science ®Google Scholar
• Kamphuis MM, Paridaans N, Porcelijn L, De Haas M, Van Der Schoot CE, Brand A, Bonsel GJ, Oepkes D. Screening in pregnancy for fetal or neonatal alloimmune thrombocytopenia: Systematic review. BJOG 2010;117:1335–1343
   PubMed Web of Science ®Google Scholar
• Skogen B, Killie MK, Kjeldsen-Kragh J, Ahlen MT, Tiller H, Stuge TB, Husebekk A. Reconsidering fetal and neonatal alloimmune thrombocytopenia with a focus on screening and prevention. Expert Rev Hematol 2010;3:559–566
   PubMed Web of Science ®Google Scholar
• Muniz-Diaz E, Ginovart Galiana G. Fetal-neonatal alloimmune thrombocytopenia. Anales de Pediatria 2003;58:562–567
   PubMedGoogle Scholar
• Porcelijn L, Van den Akker ES, Oepkes D. Fetal thrombocytopenia. Semin Fetal Neonatal Med 2008;13:223–230
   PubMedGoogle Scholar
• Taaning E, Jensen L, Varming K. Simultaneous occurrence of foetal and neonatal alloimmune thrombocytopenia and neonatal neutropenia due to maternal neutrophilic autoantibodies: A case study and review of the literature. Acta Paediatrica 2012;101:896–899
   PubMedGoogle Scholar
• Durand-Zaleski I, Schlegel N, Blum-Boisgard C, Uzan S, Dreyfus M, Kaplan C. Screening primiparous women and newborns for fetal/neonatal alloimmune thrombocytopenia: A prospective comparison of effectiveness and costs. Immune Thrombocytopenia Working Group. Am J Perinatol 1996;13:423–431
   PubMedGoogle Scholar
• Kiefel V, Santoso S, Weisheit M, Mueller-Eckhardt C. Monoclonal antibody-specific immobilization of platelet antigens (MAIPA): A new tool for the identification of platelet-reactive antibodies. Blood 1987;70:1722–1726
   PubMed Web of Science ®Google Scholar
• Rodriguez Wilhelmi P, Aranguren A, Muniz E, Aranburu E, Ezpeleta I, Ardanaz MF, Ayape ML. [Foetal/neonatal alloimmune thrombocytopenia. A review and case report]. Anales del Sistema Sanitario de Navarra. 2008;31:281–287
   PubMedGoogle Scholar
• Kaplan C, Freedman J, Foxcroft Z, Husebekk A, Metcalfe P, Muniz-Diaz E, Ouwehand W, Panzer S, Rozman P, Skogen B, et al. Monoclonal platelet antigen capture assays (MAIPA) and reagents: A statement. Vox Sanguinis 2007;93:298–299
   PubMedGoogle Scholar
• Allen D, Ouwehand WH, de Haas M, Kekomaki R, Kaplan C, Metcalfe P. Interlaboratory variation in the detection of HPA-specific alloantibodies and in molecular HPA typing. Vox Sanguinis 2007;93:316–324
   PubMedGoogle Scholar
• Murphy MF, Verjee S, Greaves M. Inadequacies in the postnatal management of fetomaternal alloimmune thrombocytopenia (FMAIT). Brit J Haematol 1999;105:123–126
   PubMedGoogle Scholar
• Risson DC, Davies MW, Williams BA. Review of neonatal alloimmune thrombocytopenia. J Paediatr Child Health 2012;48:816–822
   PubMed Web of Science ®Google Scholar
• Peterson JA, McFarland JG, Curtis BR, Aster RH. Neonatal alloimmune thrombocytopenia: Pathogenesis, diagnosis and management. Brit Journal Haematol 2013;161:3–14
   PubMed Web of Science ®Google Scholar
• Sachs UJ. Fetal/neonatal alloimmune thrombocytopenia. Thromb Res 2013;131:S42–S46
   PubMedGoogle Scholar
• Porcelijn L, Huiskes E, Comijs-van Osselen I, Chhatta A, Rathore V, Meyers M, de Haas M. A new bead-based human platelet antigen antibodies detection assay vs the monoclonal antibody immobilization of platelet antigens assay. Transfusion 2014;54:1486–1492
   PubMedGoogle Scholar
• Chong W, Metcalfe P, Mushens R, Lucas G, Ouwehand WH, Navarrete CV. Detection of human platelet antigen-1a alloantibodies in cases of fetomaternal alloimmune thrombocytopenia using recombinant beta3 integrin fragments coupled to fluorescently labeled beads. Transfusion 2011;51:1261–1270
   PubMedGoogle Scholar
• Thibaut J, Merieux Y, Rigal D, Gillet G. A novel assay for the detection of anti-human platelet antigen antibodies (HPA-1a) based on peptide aptamer technology. Haematologica 2012;97:696–704
   PubMedGoogle Scholar
• Hayashi T, Amakishi E, Matsuyama N, Yasui K, Furuta RA, Hori Y, Tanaka S, Fukumori Y, Hirayama F. Detection of anti-human platelet antibodies against integrin alpha2beta1 using cell lines. Blood Transfus 2012;12:273–280
   Google Scholar